活动记录
多导睡眠图
快速眼动睡眠行为障碍
帕金森病
物理医学与康复
医学
快速眼动睡眠
医学诊断
疾病
眼球运动
物理疗法
脑电图
昼夜节律
内科学
精神科
眼科
病理
作者
Flavio Raschellà,Stefano Scafa,Alessandro Puiatti,Eduardo Martin Moraud,Pietro‐Luca Ratti
摘要
Objectives Rapid eye movement sleep behavior disorder (RBD) is a potentially harmful, often overlooked sleep disorder affecting up to 70% of Parkinson's disease patients. Current diagnosis relies on nocturnal video‐polysomnography, which is an expensive and cumbersome examination requiring specific clinical expertise. Here, we explored the use of wrist actigraphy to enable automatic RBD diagnoses in home settings. Methods A total of 26 Parkinson's disease patients underwent 2‐week home wrist actigraphy, followed by two in‐laboratory evaluations. Patients were classified as RBD versus non‐RBD based on dream enactment history and video‐polysomnography. We comprehensively characterized patients' movement patterns during sleep using actigraphic signals. We then trained machine learning classification algorithms to discriminate patients with or without RBD using the most relevant features. Classification performance was quantified with respect to clinical diagnosis, separately for in‐laboratory and at‐home recordings. Performance was further validated in a control group of non‐Parkinson's disease patients with other sleep conditions. Results To characterize RBD, actigraphic features extracted from both (1) individual movement episodes and (2) global nocturnal activity were critical. RBD patients were more active overall, and showed movements that were shorter, of higher magnitude, and more scattered in time. Using these features, our classification algorithms reached an accuracy of 92.9 ± 8.16% during in‐clinic tests. When validated on home recordings in Parkinson's disease patients, accuracy reached 100% over a 2‐week window, and was 94.4% in non‐Parkinson's disease control patients. Features showed robustness across tests and conditions. Interpretation These results open new perspectives for faster, cheaper, and more regular screening of sleep disorders, both for routine clinical practice and clinical trials. ANN NEUROL 2023;93:317–329
科研通智能强力驱动
Strongly Powered by AbleSci AI